Medicare enrollees won’t pay more than $35 a month for insulin as new drug provisions kick in
Senior citizens and other Medicare enrollees can now get a break on the cost of their insulin.
They won’t pay more than $35 a month for each insulin prescription that’s covered by their Medicare Part D plan. And they won’t be subject to a deductible for insulin.
It’s one of several drug-related provisions of the Inflation Reduction Act that are kicking in this year. The law, which Congress passed last summer, aims to make it easier for Americans, particularly the elderly, to afford their medications. The other measures taking effect in 2023 include allowing seniors to get more vaccines at no charge and penalizing drugmakers that raise prices higher than inflation.
For Medicare enrollees who take insulin via a pump, which is covered by Part B, the $35 monthly cap starts on July 1.
Though insulin was discovered more than a century ago and is relatively inexpensive to manufacture, its price has soared in recent years. This has contributed to about 1.3 million Americans with diabetes – or 1 in 6 insulin users – rationing their insulin in the…
Read the full article here
Disclaimer: This report is auto-generated from the various news services (RSS Feeds). pressenachrichten.com holds no responsibility for its content.